Literature DB >> 29975287

Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women: implications for late onset Alzheimer's disease.

Roksana Karim1,2, Melissa Koc1, Jamaica R Rettberg3, Howard N Hodis1,2,4, Victor W Henderson5, Jan A St John1,2, Hooman Allayee1, Roberta D Brinton4,6,7, Wendy J Mack1,2.   

Abstract

OBJECTIVE: We hypothesized the association of metabolic profile on cognition in postmenopausal women will be greater among ApoE4 carriers compared with noncarriers.
METHODS: Metabolic biomarkers and measures of global cognition, executive functions, and verbal memory, collected among postmenopausal females, were used in this analysis. Clustering analyses of metabolic biomarkers revealed three phenotypes: healthy, predominantly hypertensive, and poor metabolic with (borderline normal laboratory values). General linear models tested whether an association of metabolic cluster with cognition differed by ApoE4 genotype.
RESULTS: In the total sample of 497 women, verbal memory was lower in the poor metabolic cluster (P = 0.04). Among ApoE4+ women, performance in all cognitive domains was lowest in the poor metabolic cluster. Differences in executive functions among metabolic clusters were detected only in ApoE4+ women (P value for interaction = 0.003).
CONCLUSIONS: In a general population of postmenopausal women, association between poor metabolic profile with reduction in cognitive performance is more apparent in women who carry an ApoE4 allele. These data indicate a window of opportunity for interventions to reverse the trajectory of the preclinical phase of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29975287     DOI: 10.1097/GME.0000000000001160

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  11 in total

1.  Effect of ApoE4 Genotype on the Association Between Metabolic Phenotype and Subclinical Atherosclerosis in Postmenopausal Women.

Authors:  Intira Sriprasert; Wendy Jean Mack; Howard Neil Hodis; Hooman Allayee; Roberta Diaz Brinton; Roksana Karim
Journal:  Am J Cardiol       Date:  2019-07-15       Impact factor: 2.778

2.  How would we combat menopause as an Alzheimer's risk factor?

Authors:  Lisa Mosconi; Roberta Diaz Brinton
Journal:  Expert Rev Neurother       Date:  2018-08-13       Impact factor: 4.618

Review 3.  A tale of two systems: Lessons learned from female mid-life aging with implications for Alzheimer's prevention & treatment.

Authors:  Aarti Mishra; Yiwei Wang; Fei Yin; Francesca Vitali; Kathleen E Rodgers; Maira Soto; Lisa Mosconi; Tian Wang; Roberta D Brinton
Journal:  Ageing Res Rev       Date:  2021-12-17       Impact factor: 10.895

Review 4.  Precision hormone therapy: identification of positive responders.

Authors:  Y J Kim; R D Brinton
Journal:  Climacteric       Date:  2021-02-22       Impact factor: 3.005

5.  Association of dyslipidaemia with Alzheimer's disease in a cohort of postmenopausal women.

Authors:  Ning Li; Xiaoying Xu; Shuai Mao; Ye Jiang; Yadong Hu; Ruowei Xing; Yajing Chen; Junxing Ye; Li Ling; Xianshang Zeng; Guowei Han
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

6.  Tract Specificity of Age Effects on Diffusion Tensor Imaging Measures of White Matter Health.

Authors:  Stephanie Matijevic; Lee Ryan
Journal:  Front Aging Neurosci       Date:  2021-03-15       Impact factor: 5.750

7.  Subclinical carotid artery atherosclerosis and cognitive function in older adults.

Authors:  Felice Lin; Judy Pa; Roksana Karim; Howard N Hodis; S Duke Han; Victor W Henderson; Jan A St John; Wendy J Mack
Journal:  Alzheimers Res Ther       Date:  2022-05-07       Impact factor: 8.823

Review 8.  Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential.

Authors:  Yashi Mi; Guoyuan Qi; Roberta Diaz Brinton; Fei Yin
Journal:  Antioxid Redox Signal       Date:  2020-04-21       Impact factor: 8.401

9.  APOE genotype affects metabolic and Alzheimer-related outcomes induced by Western diet in female EFAD mice.

Authors:  Amy Christensen; Christian J Pike
Journal:  FASEB J       Date:  2018-12-03       Impact factor: 5.834

Review 10.  Transitions in metabolic and immune systems from pre-menopause to post-menopause: implications for age-associated neurodegenerative diseases.

Authors:  Yiwei Wang; Aarti Mishra; Roberta Diaz Brinton
Journal:  F1000Res       Date:  2020-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.